Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Revolution Medicines, Inc. - Common Stock (NQ:RVMD)

102.35 +2.56 (+2.57%)
Streaming Delayed Price Updated: 3:30 PM EST, Feb 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Revolution Medicines, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Revolution Medicines Crashes 39% On Lackluster Test Results In Cancer Treatment ↗
The results were "at best, in line" with expectations for lung and pancreatic cancer treatment. 
Via Investor's Business Daily
News headline image
Dow Falls Over 100 Points; Chicago Fed National Activity Index Increases In September ↗
U.S. stocks traded lower this morning, with the Dow Jones index falling over 100 points on Monday. Following the market opening Monday, The Dow traded down 0.41% to 32,991.58 while the NASDAQ fell... 
Via Benzinga
Topics Economy Stocks
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Revolution Medicines Stock Joins Elite Club With RS Ratings Over 90 ↗
Revolution Medicines shows improving price performance, earning an upgrade to its IBD Relative Strength Rating. 
Via Investor's Business Daily
News headline image
Lululemon, PCTEL, Consolidated Communications, Other Stocks Jumping Higher On Monday ↗
U.S. stocks traded higher, with the Dow Jones gaining more than 350 points on Monday. Here are some stocks recording big gains in today’s session. 
Via Benzinga
Topics Stocks
News headline image
Expert Ratings for Revolution Medicines ↗
 
Via Benzinga
News headline image
Why Shares of Revolution Medicines Were Popping on Friday ↗
The company released positive phase 1/1b trial data on two cancer therapies. 
Via The Motley Fool
News headline image
Why Is Cancer Focused Revolution Medicines Stock Trading Higher Today? ↗
Revolution Medicines Inc (NASDAQ: RVMD) released preliminary data for RMC-6236, its RASMULTI(ON) Inhibitor, and RMC-6291, its RASG12C(ON) Inhibitor, from the  
Via Benzinga
News headline image
Top 4 Health Care Stocks That Are Preparing To Pump This Quarter ↗
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Stifel Maintains Buy Rating for Revolution Medicines: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Analyst Ratings for Revolution Medicines ↗
 
Via Benzinga
News headline image
Revolution Medicines Earnings Preview ↗
 
Via Benzinga
News headline image
Revolution Medicines Earnings Preview ↗
 
Via Benzinga
News headline image
Where Revolution Medicines Stands With Analysts ↗
 
Via Benzinga
News headline image
Why Revolution Medicines Stock Is Trading Lower ↗
Revolution Medicines Inc (NASDAQ: RVMD) shares are trading lower by 8.77% to $24.18 Thursday morning after the company announced a $300 million offering of common stock. 
Via Benzinga
News headline image
Top 5 Health Care Stocks That May Crash In Q3 ↗
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
News headline image
Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares gained 188.8% to $4.13. The stock is now on the Regulation SHO "threshold security" list. 
Via Benzinga
News headline image
Revolution Medicines Earnings Preview ↗
 
Via Benzinga
Where Revolution Medicines Stands With Analysts ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Revolution Medicines To Acquire EQRx In All-Stock Transaction To Gain Over $1B In Additional Capital ↗
Revolution Medicines Inc (NASDAQ: RVMD) has agreed to acquire EQRx Inc (NASDAQ: EQRX) in an all-stock transaction intended to add more than $1 billion in net cash to  
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names ↗
Where is the current bull market? All indications would be that it's in biotech! The broader market is not really moving. There have been plenty of attention-grabbing headlines, and earnings season is... 
Via Benzinga
News headline image
$140M Bet On Southwest Gas? Check Out These 4 Stocks Insiders Are Buying ↗
Although US stocks closed lower on Friday, there were a few notable insider trades. 
Via Benzinga
News headline image
Why Revolution Medicines Shares Are Trading Higher Today ↗
Revolution Medicines, Inc. (NASDAQ: RMVD) shares are trading higher after the company reported better-than-expected fourth-quarter results. 
Via Benzinga
News headline image
Revolution Medicines' Early-Data Validation For Cancer Program Wins Price Target Boost By This Analyst ↗
 
Via Benzinga
News headline image
Dentsply Sirona, Chico's FAS, Kontoor Brands And Other Big Stocks Moving Higher On Tuesday ↗
U.S. stocks traded lower, with the Dow Jones dropping more than 150 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 27, 2023 ↗
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.